Dr Richard Shaffer is a leading clinical oncologist based in London and Surrey. He uses chemotherapy and radiotherapy to treat skin cancer, brain tumours, bladder and prostate cancer. He has a specialist interest in implementing the latest radiotherapy technology, including IGRT, IMRT RapidArc and Intracranial Stereotactic Radiotherapy.
Dr Richard Shaffer previously worked as a Clinical Lead for Radiotherapy in Guildford, he chaired The Network Radiotherapy Group and the Radiotherapy Strategy Group. Dr Richard Shaffer has also chaired the Radiotherapy Technology Development Group, and has led the Brain Tumour Working Group since January 2010.
He served on the Royal College of Radiologists Working Group looking into the use of radiotherapy for benign conditions. He was the principal investigator on several treatment studies in prostate cancer, skin cancer and brain tumours. He is currently supervising a clinical fellow in a programme of clinical and lab-based radiobiological research.
Before working at Royal Surrey County Hospital, Dr Richard Shaffer undertook his oncology training in London and later completed a Clinical Fellowship in Radiation Oncology (treatment of cancer with radiotherapy) in Vancouver, Canada. Whilst in Canada he completed several research projects focused on technical radiotherapy, including the comparisons of VMAT with conventional IMRT therapy and RapidArc in several disease sites such as breast, prostate, high-grade glioma, and paediatric tumours.